Article Details

Intersect ENT (NASDAQ:XENT) Upgraded to "Buy" by Canaccord Genuity

Retrieved on: 2021-01-07 09:35:45

Tags for this article:

Click the tags to see associated articles and topics

Intersect ENT (NASDAQ:XENT) Upgraded to "Buy" by Canaccord Genuity. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 134,552 shares of the medical equipment provider's stock worth $1,822,000 after buying an additional 37,280 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up